P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis
Authors
Keywords
-
Journal
NATURE MATERIALS
Volume 22, Issue 3, Pages 391-399
Publisher
Springer Science and Business Media LLC
Online
2023-03-03
DOI
10.1038/s41563-023-01481-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Stabilization of Endothelial Receptor Arrays by a Polarized Spectrin Cytoskeleton Facilitates Rolling and Adhesion of Leukocytes
- (2020) Sivakami Mylvaganam et al. Cell Reports
- Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
- (2020) Jessica I. Griffith et al. Pharmaceutics
- Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity
- (2020) Duhyeong Hwang et al. Nanomedicine-Nanotechnology Biology and Medicine
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Photodynamic opening of the blood-brain barrier to high weight molecules and liposomes through an optical clearing skull window
- (2018) Chao Zhang et al. Biomedical Optics Express
- State-of-the-art of microbubble-assisted blood-brain barrier disruption
- (2018) Kang-Ho Song et al. Theranostics
- Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
- (2017) Aviram Mizrachi et al. Nature Communications
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
- (2017) Giles W. Robinson et al. Oncotarget
- Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome
- (2017) Shiran Ferber et al. eLife
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
- (2016) Timothy N. Phoenix et al. CANCER CELL
- P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
- (2016) Y. Shamay et al. Science Translational Medicine
- Precision Nanomedicine in Neurodegenerative Diseases
- (2014) Meir Goldsmith et al. ACS Nano
- Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
- (2014) Muna Aryal et al. ADVANCED DRUG DELIVERY REVIEWS
- Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae
- (2014) J. Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Pharmacokinetic-Pharmacodynamic Analysis of Vismodegib in Preclinical Models of Mutational and Ligand-Dependent Hedgehog Pathway Activation
- (2011) H. Wong et al. CLINICAL CANCER RESEARCH
- Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
- (2011) Giuseppe De Rosa et al. CURRENT DRUG METABOLISM
- MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice
- (2011) Weiguo Zou et al. JOURNAL OF CLINICAL INVESTIGATION
- PTHrP Treatment Fails to Rescue Bone Defects Caused by Hedgehog Pathway Inhibition in Young Mice
- (2011) Jillian L. Brechbiel et al. TOXICOLOGIC PATHOLOGY
- Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
- (2008) Laure Bachelet et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Transient Inhibition of the Hedgehog Pathway in Young Mice Causes Permanent Defects in Bone Structure
- (2008) Hiromichi Kimura et al. CANCER CELL
- A role for leukocyte-endothelial adhesion mechanisms in epilepsy
- (2008) Paolo F Fabene et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started